| Original language | English (US) |
|---|---|
| Pages (from-to) | 1546-1550 |
| Number of pages | 5 |
| Journal | Journal of the American Society of Nephrology |
| Volume | 32 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2021 |
Bibliographical note
Funding Information:This work was supported by the US Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, the Hennepin Healthcare Research Institute, contractor for the SRTR, as a deliverable under contract HHSH75R60220C00011 and United Network for Organ Sharing, contractor for the OPTN, under contract 250-2019-00001C.
Funding Information:
A.K. Israni reports receiving grant fundingfrom CSL Behring and has been a member of an Advisory Board to CSL Behring, outside of this work; and reports receiving research funding from Gilead outside of this work. A. Wey reports patents and inventions with University of Minnesota, clinical severity questionnaire for Sanfilippo Syndrome; and reports other interests/relationships as a biostatistician on the federal contract for the SRTR. B. Thompson reports receiving research funding from Atara Biotherapeutics. M. Pavlakis reports receiving research funding as principal investigator for the APOL1 Long-Term Kidney Transplantation Outcomes Network study and PI on a trial for the Trugraf Genomics study TruGraft Long-term Clinical Outcomes Study; and reports other interests/relationships with EBSCO Industries Inc. as content writer, and Transplant Solutions as a consultant. J. Snyder reports receiving research funding from Astellas, Atara Biotherapeutics, CSL Behring, and Novartis; reports receiving honoraria from CareDx; reports being a scientific advisor or member as Board Member of the Organ Donation and Transplantation Alliance, Board Member of Donate Life America, LifeSource Clinical Policy Board, Transplantation as Associate Editor, American Journal of Transplantation as Statistical Editor; and reports other interests/relationships as Director of SRTR. P. Stock reports being a scientific advisor or member of Encellin. R. Kandaswamy reports consultancy agreements with CareDX, Natera, TRACT Therapeutics (pending), and Vertex Pharmaceuticals; reports being scientific advisor or member with LifeSource as a Member of Clinical Policy Board, Senior Staff of Pancreas Transplantation; and reports speakers bureau with Natera and SRTR. S. Niederhaus reports receiving honoraria from the American Diabetes Association (ADA) as a speaker in 2019 on pancreas transplantation and honorarium donated to the ADA; reports being a scientific advisor or member of the National Kidney Foundation of Maryland/Delaware Board of Directors Member, OPTN Pancreas Committee Chair through July 1, 2020; and reports other interests/relationships with American Society of Transplantation, American Society of Transplant Surgeons, International Pancreas & Islet Transplant Association, National Kidney Foundation of Maryland/Delaware as above, and other academic societies.